MP-Biomedicals (formerly ICN Biomedicals) is dedicated to providing quality Life Science & research products as well as medical diagnostics. Two major acquisitions of MP-Biomedicals are Genelabs Diagnostics & Q-BIOgene.
Microtrol is one of Supernus three controlled release platforms that is comprised of a family of multiparticulate delivery technologies for delivery of both soluble and insoluble compounds via an array of release profiles. Microtrol is based on the use of
Raven Biotechnologies, Inc is a privately held biotechnology company focused on the rapid simultaneous discovery of drug targets on the cell surface and the antibody...
MacroGenics, Inc. is developing immunotherapeutics, including monoclonal antibodies, to treat patients with cancer, autoimmune disorders, allergy, or infectious diseases.
Galapagos is a discovery company focused on the identification of disease modifying drug targets by functionally screening human disease models and the subsequent progression of these targets into drug discovery
Founded in 1995, Asymchem Laboratories is a manfacturer of advanced chemical intermediates for the pharmaceutical/biotech industry, either by custom synthesis or by contract.
This magazine is the leading publication for scientists, researchers, laboratory and IT professionals who buy and use computer technology for scientific applications, including pharmaceutical and biotech research and development.
LRIG is a non-profit special interest group focused on laboratory automation. Among the topics discussed are the uses of laboratory automation in high throughput screening, drug discovery, and biobanking.
Metabolon is an industry leader in metabolomics and the discovery of biomarkers. Metabolomics is a powerful, new scientific approach for drug discovery and development. Metabolon can conduct a metabolomics analysis for your company.
Drug Discovery & Development, a Reed Business Information publication, delivers timely and informative coverage of the latest tools and technologies shaping the dynamic world of drug discovery research. Topics include the latest developments in HTS, genom
Welcome to American Drug Discovery, the journal dedicated entirely to the subject of drug discovery. American Drug Discovery is a bi-monthly publication for the pharmaceutical and biotech industries throughout North America.
Minerva Medical was acquired by Quintiles Transnational Corporation in June 1999. Minerva is a clinical trial, site management organisation with an international reputation for patient recruitment and management of clinical trials.
Quintiles Transnational Corp. is the world's leading provider of information, technology and services to bring new medicines to patients faster and improve healthcare.
Atheris is a dynamic biotechnology company with a strong technology platform and a unique expertise in exploiting bioactive molecules from venomous animals and other natural sources.
Glycosan Biosystems is a manufacturer of hydrogels for tumor xenografts; stem cell, primary cell, and cell line applications; angiogenesis; and tissue engineering.
The Pharmaceutical Technologies & Services segment provides enabling technologies and services that reduce time to market and lower the total cost of moving products from formulation to pharmacy
Dalton Chemical Laboratories Inc. has been providing academia and the biotechnology and pharmaceutical industries with high quality innovative products at competitive prices for 15 years. We are a unique chemistry solution provider.
